Cytomegalovirus (CMV) Infection Therapeutic Market is Anticipated to Witness High Growth Owing to Rising incidence of CMV-related diseases



The global cytomegalovirus (CMV) infection therapeutic market primarily deals with the treatment of cytomegalovirus or CMV infection. CMV is a type of herpes virus that causes infections in humans. Cytomegalovirus is common globally and infected individuals may experience no symptoms or mild symptoms like fever, tiredness, and lack of appetite which are often confused for flu symptoms. However, CMV infection can also be harmful if contracted by pregnant women, transplant patients, or immunocompromised individuals. The CMV infection therapeutic aids in treating various CMV-related diseases such as CMV pneumonia, CMV colitis, CMV encephalitis, CMV retinitis. The increasing prevalence of CMV infections and related diseases across the globe is prompting the development of novel treatments.

The global CMV infection therapeutic market is estimated to be valued at US$ 231.4 Mn in 2024 and is expected to exhibit a CAGR of 7.1% over the forecast period 2024-2031.

Key Takeaways

Key players operating in the Cytomegalovirus (CMV) infection therapeutic are Moderna, Trellis Bioscience, SpyBiotech, Vical, Atara Biotherapeutics. Moderna and Trellis Bioscience are developing RNA vaccines for CMV treatment. Whereas SpyBiotech is developing peptide-based therapeutic vaccines. Vical has developed genetically modified cell therapies for CMV treatment. Atara Biotherapeutics is developing T-cell therapies against CMV infection.

The key opportunities in the CMV infection therapeutic market include increasing R&D investments for developing novel treatment mechanisms like gene therapy, immunotherapy, antibody therapies, etc. Growing adult and pediatric transplant procedures are also necessitating efficient CMV infection management options.

Globally, companies are actively pursuing regional and global expansion initiatives. Companies are engaged in establishing regional manufacturing facilities and R&D centers in high growth markets like North America, Europe, Asia Pacific to cater to the local demand. Partnerships and licensing agreements are helping companies to access novel technologies and establish presence in new geographies.

Market drivers: The rising incidence and prevalence of CMV-related diseases is a major market driver. Growing rates of organ transplantation and immunocompromised population are also fueling the demand for CMV infection treatment options.

Market restraints: High R&D costs associated with drug development is a key challenge. Currently available treatment landscape also has limitations in terms of efficacy, resistance, and side effects which hinders market growth. Regulatory challenges for cell and gene therapies further restrains the market expansion.


Segment Analysis
The cytomegalovirus (CMV) infection therapeutic market is dominated by ganciclovir which is the first-line treatment for CMV. Ganciclovir holds the largest market share as it is the only approved drug by FDA for treatment and prevention of CMV infection and diseases. It is prescribed for conditions like retinitis in AIDS patient and organ transplant recipients. Foscarnet sodium is the second largest segment as it is used for treatment of CMV infection in patients with renal impairment or those who do not respond to or tolerate ganciclovir.

Global Analysis
North America holds the largest share in the CMV infection therapeutics market due to increasing healthcare spending and growing prevalence of CMV infection due to rising organ transplantations and AIDS cases. Europe is the second largest market due to large patient pool and high awareness. However, Asia Pacific region is expected to witness highest growth during the forecast period owing to improving healthcare infrastructure, increasing healthcare spending, rising geriatric population, and growing medical tourism industry. Key players are focusing on emerging countries especially China and India for business expansion considering high unmet needs.

Get more insights on this topic : https://justpaste.it/csfr8

What Are The Key Data Covered In This Cytomegalovirus (CMV) Infection Therapeutic  Market Report?

:- Market CAGR throughout the predicted period

:- Comprehensive information on the aspects that will drive the Cytomegalovirus (CMV) Infection Therapeutic 's growth between 2024 and 2031.

:- Accurate calculation of the size of the Cytomegalovirus (CMV) Infection Therapeutic  and its contribution to the market, with emphasis on the parent market

:- Realistic forecasts of future trends and changes in consumer behaviour

:- Cytomegalovirus (CMV) Infection Therapeutic  Industry Growth in North America, APAC, Europe, South America, the Middle East, and Africa

:- A complete examination of the market's competitive landscape, as well as extensive information on vendors

:- Detailed examination of the factors that will impede the expansion of Cytomegalovirus (CMV) Infection Therapeutic  vendors

About Author:

Ravina Pandya, Content Writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. (https://www.linkedin.com/in/ravina-pandya-1a3984191)

 

*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it

Comments

Post a Comment

Popular posts from this blog

Laser Projection Market is to Witness High Growth Owing to Advancements in RGB Laser Projection Technology

Image
  The laser projection market involves the usage of laser diodes and phosphor wheels to project images instead of traditional light bulbs and rotating color wheels. Laser projection technology offers a variety of benefits over conventional projection including high brightness levels, long lifespan, high resolutions, and high contrast ratios. Laser projectors are increasingly being used for entertainment and commercial applications such as cinemas, digital signage, and conferences & seminars. The demand for   Laser Projection Market is driven by the superior image quality, higher resolutions and brighter images they provide compared to conventional projectors. The laser projection market is estimated to be valued at   USD 17.52 Bn in 2024   and is expected to reach   USD 56.28 Bn by 2031,  growing at a compound annual growth rate  (CAGR) of 18.1% from 2024 to 2031.  Key Takeaways Key players: Key players operating in the laser projection...
Read more

AL Amyloidosis Diagnostics is to Witness High Growth due to Advancements in Molecular Diagnostics and Flow Cytometry

Image
AL amyloidosis, also called primary (AL) amyloidosis, is a plasma cell disorder characterized by the buildup of abnormal protein deposits known as amyloid in tissues and organs. AL amyloidosis can affect the heart, kidneys, liver, nervous system, and digestive system. Early and precise diagnosis of AL Amyloidosis Diagnostics Market is very important for effective treatment and management of the disease. The AL amyloidosis diagnostic market is estimated to be valued at  USD 1.068 billion in 2024   and is expected to reach   USD 1.693 billion by 2031 , growing at a compound annual growth rate   (CAGR) of 6.8% from 2024 to 2031. Key Takeaways Key players operating in the AL amyloidosis diagnostics are Siemens Healthineers, Abbott Laboratories, IMMUNOConcepts, PrognostiX, Ark Diagnostics. The key opportunities in the AL amyloidosis diagnostics market include development of minimally invasive diagnostic techniques, adoption of PET imaging for diagnosis, advanceme...
Read more

Navigating the Stuttering Treatment Market: Top Solutions for Effective Speech Therapy

Image
The stuttering treatment market involves speech therapy techniques that help reduce or eliminate stuttering or stammering symptoms. Stuttering or stammering occurs when the flow of speech is disrupted by involuntary blocking, repetition, or prolongation of certain sounds. Such involuntary disruptions create difficulties in expressing thoughts fluently which can negatively impact an individual's self-confidence and social interactions. The need for effective Stuttering Market treatment solutions is rising due to the availability of advanced methods such as modified fluency shaping techniques, delayed auditory feedback devices, and self-therapy programs. The Global Stuttering Market is estimated to be valued at   USD 51.5 million in 2024   and is expected to reach   USD 150.1 million by 2031 , growing at a compound annual growth rate   (CAGR) of 11.3% from 2024 to 2031. Key Takeaways Key players operating in the stuttering treatment market are Johnson & Johns...
Read more